CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

The most amazing part of being a teacher is witnessing the look on a child’s face when they understand something they thought ...

From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...

A new continuous glucose monitor offers a one-a-year option for some people living with diabetes. It’s welcome news for ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

As diabetes cases surge across Europe, healthcare systems are grappling with an escalation, leaving millions without ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

New research presents a solution to a fundamental challenge: ensuring accurate glucose readings from wearable devices. Read more.